Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07103980
PHASE1/PHASE2

Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial

Sponsor: Shanghai Changzheng Hospital

View on ClinicalTrials.gov

Summary

This study is an exploratory clinical trial. It is intended to investigate the efficacy of mesenchymal stem cell-derived exosome nebulization in the treatment of postinfectious cough through a randomized controlled clinical study, with a view to providing better treatment options for patients with postinfectious cough, improving their quality of life, and providing reference data for the subsequent multi-center clinical trials.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-07-16

Completion Date

2025-12-30

Last Updated

2025-08-05

Healthy Volunteers

No

Interventions

DRUG

Mesenchymal stem cell derived exosome nebulization combined with compound methoxyphenamine capsule

Mesenchymal stem cell derived exosome nebulization (FITCELL 5ml nebulization QD) was combined with compound methoxyphenamine capsule ( "Asmei" 2 capsules oral TID) for cough treatment.

DRUG

Normal saline nebulization combined with the compound methoxyphenamine capsule

Normal saline nebulization (0.9% sodium chloride 5ml nebulization QD) was combined with the compound methoxyphenamine capsule ("Asmei" 2 capsules oral TID) for cough treatment.

Locations (1)

Shanghai changzheng hospital

Shanghai, Shanghai Municipality, China